SSRI Antidepressants and Bleeding in Facial Harmonization

A significant share of facial harmonization patients take antidepressants, and many do not mention it in the medical history because they consider it irrelevant to the procedure. From the standpoint of bleeding, it is not. Selective serotonin reuptake inhibitors (SSRIs) are one of the classes of drugs associated with a greater tendency to bruising, and a professional who knows this can plan, explain and record better. This guide covers how to ask, what to weigh, what never to do (stop the medication on one's own) and how to advise. Actions and medications are decisions for the qualified professional and the prescribing doctor, following the rules of their professional council.

What are SSRIs and why do they matter in facial harmonization?

SSRIs are very commonly used antidepressants, indicated for depression, anxiety disorders, obsessive-compulsive disorder and other conditions. They work by increasing the availability of serotonin in the nervous system.

Serotonin also plays a role in platelets, which take it up and use it to signal clot formation. With reduced uptake, platelet function may become less efficient, and some patients develop a greater tendency to bruises and bleeding after minor trauma, such as punctures.

For facial harmonization, this means:

• a higher chance of ecchymosis after filler and toxin injections;
• bruises that may take longer to resolve;
• the need for a candid conversation about expectations and recovery time;
• attention to the sum with other factors that affect bleeding.

The size of the effect varies between patients and between drugs, and it is not possible to predict who will bruise more. So the reasoning is one of caution and documentation, not prohibition.

How to ask in the medical history

Many patients answer "no" to "do you take any continuous medication?" because they do not consider an antidepressant a "real" medication. A more specific question helps.

For the full picture, see medical history in facial harmonization. A useful phrase is: "Some medications, including mental health ones, can increase the chance of bruising. May I write down what you take?"

What to change in planning

SSRI use rarely rules out the procedure. More commonly, you adjust the logistics and the conversation:

1. Inform the risk of ecchymosis and hematoma before any decision, with a realistic timeline.
2. Avoid scheduling close to important events, when possible.
3. Consider the set of bleeding factors: other medications, supplements and history.
4. Choose the technique and timing by your own judgment, mindful of the local risk of each area.
5. Guide the aftercare with steps to reduce trauma and follow the progress.
6. Talk with the prescriber when the doubt is relevant, with the patient's knowledge.

What never to do

Also avoid promising "no bruising" to any patient, on an SSRI or not. Bruising is an inherent risk of injectable procedures, and the consent should name it.

What to do if a bruise appears

A small, superficial bruise is usually only cosmetic and resolves on its own over time. For larger bruises, or those that are tense, painful or in high-risk areas, an in-person assessment is essential. Always tell it apart from vascular signs (pallor, intense pain, lace-like mottling). The reasoning is in vascular occlusion and in safety and complications: overview.

Supportive measures, such as advising relative rest, avoiding local heat in the first hours and keeping contact open, are at the professional's discretion. For monitoring progress, the clinical follow-up visit serves to reassess. On supplements used to "help," see arnica, bromelain and bruising.

How to talk with the patient

This conversation respects the patient's confidentiality, autonomy and mental health.

Records and consent

Note the medication (name, since when, who prescribed it), the conversation about the risk, the planning decisions and the instructions. The informed consent should include hematoma and ecchymosis among the possible complications. Mental health medications are sensitive data: handle them carefully under the LGPD (Brazil's data protection law) and restrict access. The record is covered in patient records and documentation in HOF.

Where Harmy comes in

Common mistakes

1. Not asking about mental health. Many patients do not connect the antidepressant with the procedure. The question must be asked gently and confidentially.
2. Reacting with surprise or judgment. Antidepressant use is common, and the professional's reaction determines whether the patient will be honest in later visits.
3. Promising no bruising. No patient, on an SSRI or not, has that guarantee.
4. Ignoring the sum of factors. SSRI, anti-inflammatory, supplement and a well-vascularized area add up risk, and the calculation must be done together.
5. Not recording. Without notes, the history is lost, and the conversation about hematoma has no basis.

When to postpone or adjust the plan

Some scenarios call for more caution than routine:

• a patient with an important social event in the following days who does not accept the risk of bruises;
• a history of extensive bruising in previous procedures;
• combined use of several medications that affect bleeding;
• a psychiatric condition in an unstable phase, in which aesthetics may be taking a place that is not its own;
• doubt about what the patient actually takes.

In these situations, postponing or splitting the plan into stages is usually wiser than pressing ahead. Explain the reason clearly and leave the door open to resume when the situation is more favorable. The reasoning behind staged plans is in staged plan.